GlaxoSmithKline Consumer Healthcare Q3 PAT seen up 17.1% YoY to Rs. 191.6 cr: Prabhudas Lilladher

Prabhudas Lilladher has come out with its third quarter (October-December’ 18) earnings estimates for the Consumer sector. The brokerage house expects GlaxoSmithKline Consumer Healthcare to report net profit at Rs. 191.6 crore up 17.1% year-on-year (down 30.5% quarter-on-quarter).

Net Sales are expected to increase by 10.5 percent Y-o-Y (down 10.1 percent Q-o-Q) to Rs. 1,143.3 crore, according to Prabhudas Lilladher.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 20.5 percent Y-o-Y (down 30.5 percent Q-o-Q) to Rs. 245.8 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.